Reviewing Sinovac Biotech (SVA) and The Competition

01:18 EST 8 Nov 2017 | Topix

Sinovac Biotech is one of 49 publicly-traded companies in the "Biopharmaceuticals" industry, but how does it weigh in compared to its competitors? We will compare Sinovac Biotech to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk. As a group, "Biopharmaceuticals" companies have a potential upside of 9.61%.

Original Article: Reviewing Sinovac Biotech (SVA) and The Competition


More From BioPortfolio on "Reviewing Sinovac Biotech (SVA) and The Competition"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...